Illumina(ILMN.US)

Last Updated 19:00:00 ET
longbridge loading

Illumina Earnings Call Signals Confident Clinical Pivot

Tip Ranks·
US
ILMN
-1.33%
US
BBH
+0.22%
US
BIB
+3.43%
Tip Ranks·
US
ILMN
-1.33%
US
BBH
+0.22%
US
BIB
+3.43%

Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact | ILMN Stock News

StockTitan·
US
ILMN
-1.33%
US
FBT
+0.60%
US
LABU
+9.50%
StockTitan·
US
ILMN
-1.33%
US
FBT
+0.60%
US
LABU
+9.50%

10:30 ETCancer Biomarkers Market worth $54.48 billion by 2032 | MarketsandMarkets™

prnewswire·
US
RHHBY
+0.50%
US
TMO
-0.90%
US
ILMN
-1.33%
prnewswire·
US
RHHBY
+0.50%
US
TMO
-0.90%
US
ILMN
-1.33%

Illumina Inc. Stock Underperforms Thursday When Compared To Competitors

MarketWatch Automated·
US
ILMN
-1.33%
US
IBB
+1.76%
US
LABU
+9.50%
MarketWatch Automated·
US
ILMN
-1.33%
US
IBB
+1.76%
US
LABU
+9.50%

Assessing Illumina (ILMN) Valuation After Strong Recent Share Price Gains

Simplywall·
US
ILMN
-1.33%
US
SBIO
+2.20%
US
BIB
+3.43%
Simplywall·
US
ILMN
-1.33%
US
SBIO
+2.20%
US
BIB
+3.43%

The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why

Simplywall·
US
ILMN
-1.33%
US
LABU
+9.50%
US
SBIO
+2.20%
Simplywall·
US
ILMN
-1.33%
US
LABU
+9.50%
US
SBIO
+2.20%

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day

MarketWatch Automated·
US
ILMN
-1.33%
US
IHI
+0.23%
MarketWatch Automated·
US
ILMN
-1.33%
US
IHI
+0.23%
© 2026 Longbridge｜Disclaimer